Practice Parameter for the Use of Stimulant Medications in the Treatment of Children, Adolescents, and Adults

This practice parameter describes treatment with stimulant medication. It uses an evidence-based medicine approach derived from a detailed literature review and expert consultation. Stimulant medications in clinical use include methylphenidate, dextroamphetamine, mixed-salts amphetamine, and pemoline. It carries FDA indications for treatment of attention-deficit/hyperactivity disorder and narcolepsy.

[1]  L. Shuster,et al.  Sensitization of mice to methylphenidate , 2004, Psychopharmacology.

[2]  R. Hu.  Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) , 2003 .

[3]  R. Pary,et al.  Attention Deficit Disorder in Adults , 2002, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[4]  J. Swanson,et al.  Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/hyperactivity disorder. , 2001, Pediatrics.

[5]  W. Pelham,et al.  Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings. , 2001, Pediatrics.

[6]  A. Erkanli,et al.  Stimulant treatment for children: a community perspective. , 2000, Journal of the American Academy of Child and Adolescent Psychiatry.

[7]  J. Swanson,et al.  The Texas Children's Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention-Deficit/Hyperactivity Disorder. Part I. Attention-Deficit/Hyperactivity Disorder. , 2000, Journal of the American Academy of Child and Adolescent Psychiatry.

[8]  J. Swanson,et al.  The Texas Children's Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention-Deficit/Hyperactivity Disorder. Part II: Tactics. Attention-Deficit/Hyperactivity Disorder. , 2000, Journal of the American Academy of Child and Adolescent Psychiatry.

[9]  S. Risch,et al.  Single-dose pharmacokinetics of methylphenidate in CYP2D6 extensive and poor metabolizers. , 2000, Journal of clinical psychopharmacology.

[10]  E. Susser,et al.  Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design. , 2000, The American journal of psychiatry.

[11]  F. Lynch,et al.  Trends in the prescribing of psychotropic medications to preschoolers. , 2000, JAMA.

[12]  L. E. Arnold,et al.  Methyiphenidate vs. amphetamine: Comparative review , 2000 .

[13]  Russell A. Barkley,et al.  ADHD and The Nature of Self-Control , 1997, Journal of Cognitive Psychotherapy.

[14]  J. Kramer,et al.  Stimulant treatment in young boys with symptoms suggesting childhood mania: a report from a longitudinal study. , 2000, Journal of child and adolescent psychopharmacology.

[15]  C. Varley.  Sudden death of a child treated with imipramine. Case study. , 2000, Journal of child and adolescent psychopharmacology.

[16]  M. Monuteaux,et al.  A pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder. , 1999, The American journal of psychiatry.

[17]  Stephen P. Hinshaw,et al.  A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. , 1999, Archives of general psychiatry.

[18]  J. Swanson,et al.  A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder. , 1999, Journal of the American Academy of Child and Adolescent Psychiatry.

[19]  I. Shoulson,et al.  Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children , 1999, Clinical pharmacology and therapeutics.

[20]  G. LeFever,et al.  The extent of drug therapy for attention deficit-hyperactivity disorder among children in public schools. , 1999, American journal of public health.

[21]  J. Biederman,et al.  Risperidone treatment for juvenile bipolar disorder: a retrospective chart review. , 1999, Journal of the American Academy of Child and Adolescent Psychiatry.

[22]  R. Schachar,et al.  Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder? , 1999, Journal of the American Academy of Child and Adolescent Psychiatry.

[23]  C. Hoven,et al.  Are stimulants overprescribed? Treatment of ADHD in four U.S. communities. , 1999, Journal of the American Academy of Child and Adolescent Psychiatry.

[24]  H. Feldman,et al.  Efficacy of methylphenidate among preschool children with developmental disabilities and ADHD. , 1999, Journal of the American Academy of Child and Adolescent Psychiatry.

[25]  S. Faraone,et al.  Absence of Effect of Stimulants on the Pharmacokinetics of Desipramine in Children , 1999, Pharmacotherapy.

[26]  J. Swanson,et al.  Combining methylphenidate and clonidine: a clinically sound medication option. , 1999, Journal of the American Academy of Child and Adolescent Psychiatry.

[27]  R. Tannock,et al.  Response to methylphenidate in children with ADHD and comorbid anxiety. , 1999, Journal of the American Academy of Child and Adolescent Psychiatry.

[28]  J. Epstein,et al.  Conners Rating Scales-Revised. , 1999 .

[29]  J. Swanson,et al.  Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of children with Attention-deficit/hyperactivity disorder. , 1999, Archives of general psychiatry.

[30]  N. Lambert,et al.  Prospective Study of Tobacco Smoking and Substance Dependencies Among Samples of ADHD and Non-ADHD Participants , 1998, Journal of learning disabilities.

[31]  W. Bernet.  Introduction Practice Parameters Past, Present, and Future , 1998 .

[32]  J A Cipkala-Gaffin,et al.  Diagnosis and treatment of attention-deficit/hyperactivity disorder. , 1998, Perspectives in psychiatric care.

[33]  N. Volkow,et al.  Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. , 1998, The American journal of psychiatry.

[34]  L. Toussaint,et al.  Methylphenidate in early poststroke recovery: a double-blind, placebo-controlled study. , 1998, Archives of physical medicine and rehabilitation.

[35]  L. Greenhill.  The Use of Psychotropic Medication in Preschoolers: Indications, Safety, and Efficacy , 1998, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[36]  S. Faraone,et al.  Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder. , 1998, The American journal of psychiatry.

[37]  J. Swanson,et al.  Analog classroom assessment of Adderall in children with ADHD. , 1998, Journal of the American Academy of Child and Adolescent Psychiatry.

[38]  Myron Genel,et al.  Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents , 1998 .

[39]  Robert Reid,et al.  Adhd Rating Scale-IV: Checklists, Norms, and Clinical Interpretation , 1998 .

[40]  J. Swanson,et al.  Reliability and validity of the SKAMP rating scale in a laboratory school setting. , 1998, Psychopharmacology bulletin.

[41]  S. Bennett,et al.  Short-term side effects of stimulant medication are increased in preschool children with attention-deficit/hyperactivity disorder: a double-blind placebo-controlled study. , 1998, Journal of child and adolescent psychopharmacology.

[42]  C. Conners,et al.  Rating scales in attention-deficit/hyperactivity disorder: use in assessment and treatment monitoring. , 1998, The Journal of clinical psychiatry.

[43]  H. Abikoff,et al.  Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder. , 1997, Archives of general psychiatry.

[44]  J. Swanson,et al.  NIMH collaborative multimodal treatment study of children with ADHD (MTA): Design, methodology, and protocol evolution , 1997 .

[45]  M. Dulcan,et al.  Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. American Academy of Child and Adolescent Psychiatry. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.

[46]  S. Bennett,et al.  Effects of methylphenidate on preschool children with ADHD: cognitive and behavioral functions. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.

[47]  C. Gillberg,et al.  Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms. A randomized, double-blind, placebo-controlled trial. , 1997, Archives of general psychiatry.

[48]  P. Jensen,et al.  Medication development and testing in children and adolescents. Current problems, future directions. , 1997, Archives of general psychiatry.

[49]  R. Tannock,et al.  Behavioral, situational, and temporal effects of treatment of ADHD with methylphenidate. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.

[50]  J. Rapoport,et al.  Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: effects of stimulant and dose. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.

[51]  C. McDougle,et al.  Risperidone treatment of children and adolescents with pervasive developmental disorders: a prospective open-label study. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.

[52]  J. McClellan,et al.  Case study: two additional sudden deaths with tricyclic antidepressants. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.

[53]  D. Safer,et al.  Increased methylphenidate usage for attention deficit disorder in the 1990s. , 1996, Pediatrics.

[54]  S. Faraone,et al.  Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays? , 1996, Journal of the American Academy of Child and Adolescent Psychiatry.

[55]  J. Swanson,et al.  Medication treatment strategies in the MTA Study: relevance to clinicians and researchers. , 1996, Journal of the American Academy of Child and Adolescent Psychiatry.

[56]  J. Biederman,et al.  Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. , 1996, Journal of the American Academy of Child and Adolescent Psychiatry.

[57]  J. Dunnick,et al.  Experimental studies on the long-term effects of methylphenidate hydrochloride. , 1995, Toxicology.

[58]  J. Swanson,et al.  Pemoline effects on children with ADHD: a time-response by dose-response analysis on classroom measures. , 1995, Journal of the American Academy of Child and Adolescent Psychiatry.

[59]  J. Swanson,et al.  More frequent diagnosis of attention deficit-hyperactivity disorder. , 1995, The New England journal of medicine.

[60]  J. Buitelaar,et al.  Prediction of clinical response to methylphenidate in children with attention-deficit hyperactivity disorder. , 1995, Journal of the American Academy of Child and Adolescent Psychiatry.

[61]  H. Koplewicz,et al.  Effects of late-afternoon methylphenidate administration on behavior and sleep in attention-deficit hyperactivity disorder. , 1995, Pediatrics.

[62]  J. Swanson,et al.  NIMH collaborative multisite multimodal treatment study of children with ADHD: I. Background and rationale. , 1995, Journal of the American Academy of Child and Adolescent Psychiatry.

[63]  R. Tannock,et al.  Differential effects of methylphenidate on working memory in ADHD children with and without comorbid anxiety. , 1995, Journal of the American Academy of Child and Adolescent Psychiatry.

[64]  J S Fowler,et al.  Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. , 1995, Archives of general psychiatry.

[65]  A. Wallace,et al.  Double-blind, placebo-controlled trial of methylphenidate in older, depressed, medically ill patients. , 1995, The American journal of psychiatry.

[66]  G. Koren,et al.  Pemoline‐associated fulminant liver failure: Testing the evidence for causation , 1995, Clinical pharmacology and therapeutics.

[67]  J. Sverd,et al.  Efficacy of methylphenidate for attention-deficit hyperactivity disorder in children with tic disorder. , 1995, Archives of general psychiatry.

[68]  S. Faraone,et al.  A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder. , 1995, Archives of general psychiatry.

[69]  A. Josephson,et al.  Combined methylphenidate and imipramine complication. , 1995, Journal of the American Academy of Child and Adolescent Psychiatry.

[70]  R Tannock,et al.  Methylphenidate and cognitive flexibility: Dissociated dose effects in hyperactive children , 1995, Journal of abnormal child psychology.

[71]  C. Popper,et al.  Sudden Death Putatively Related to Desipramine Treatment in Youth: A Fifth Case and a Review of Speculative Mechanisms , 1995 .

[72]  E. Bixler,et al.  METHYLPHENDATE AND ADHD: INFLUENCE OF AGE, IQ AND NEURODEVELOPMENTAL STATUS , 1994, Developmental medicine and child neurology.

[73]  R. Barkley,et al.  Response of children with ADHD to methylphenidate: interaction with internalizing symptoms. , 1994, Journal of the American Academy of Child and Adolescent Psychiatry.

[74]  J. Biederman,et al.  Comorbidity of attention-deficit hyperactivity and psychoactive substance use disorders. , 1994, Hospital & community psychiatry.

[75]  J. Biederman,et al.  Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder. , 1994, Journal of the American Academy of Child and Adolescent Psychiatry.

[76]  C. Berde,et al.  Dextroamphetamine or methylphenidate as adjuvants to opioid analgesia for adolescents with cancer. , 1994, Journal of pain and symptom management.

[77]  Francis M. Crinella,et al.  Effect of Stimulant Medication on Children with Attention Deficit Disorder: A “Review of Reviews” , 1993 .

[78]  M. Rapport,et al.  Side effects of methylphenidate and desipramine alone and in combination in children. , 1993, Journal of the American Academy of Child and Adolescent Psychiatry.

[79]  T. Nordahl,et al.  Effects of Acute Stimulant Medication on Cerebral Metabolism in Adults with Hyperactivity , 1993, Neuropsychopharmacology.

[80]  M. Rapport,et al.  Methylphenidate and desipramine in hospitalized children: I. Separate and combined effects on cognitive function. , 1993, Journal of the American Academy of Child and Adolescent Psychiatry.

[81]  R. Tannock,et al.  Childhood hyperactivity and psychostimulants: a review of extended treatment studies. , 1993, Journal of child and adolescent psychopharmacology.

[82]  S. Hinshaw,et al.  Covert antisocial behavior in boys with attention-deficit hyperactivity disorder: external validation and effects of methylphenidate. , 1992, Journal of consulting and clinical psychology.

[83]  F. Sallee,et al.  Pharmacodynamics of pemoline in attention deficit disorder with hyperactivity. , 1992, Journal of the American Academy of Child and Adolescent Psychiatry.

[84]  M. Fristad,et al.  The Mania Rating Scale: can it be used in children? A preliminary report. , 1992, Journal of the American Academy of Child and Adolescent Psychiatry.

[85]  S. Pliszka,et al.  Comorbidity of attention-deficit hyperactivity disorder and overanxious disorder. , 1992, Journal of the American Academy of Child and Adolescent Psychiatry.

[86]  K. Lindem,et al.  Unrecognized attention-deficit hyperactivity disorder in adults presenting for outpatient psychotherapy. , 1992, Journal of child and adolescent psychopharmacology.

[87]  T. Achenbach.  Manual for the child behavior checklist/4-18 and 1991 profile , 1991 .

[88]  P. Rosenberg,et al.  Methylphenidate in depressed medically ill patients. , 1991, The Journal of clinical psychiatry.

[89]  J. Biederman,et al.  Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. , 1991, The American journal of psychiatry.

[90]  J. Rapoport,et al.  Methylphenidate and dextroamphetamine treatments of hyperactivity: Are there true nonresponders? , 1991, Psychiatry Research.

[91]  C. Gualtieri,et al.  Neuropsychiatry and Behavioral Pharmacology , 1990, Springer New York.

[92]  Frierson Rl,et al.  Psychostimulants for depression in the medically ill. , 1991 .

[93]  R. Klein,et al.  Hyperactive boys almost grown up. V. Replication of psychiatric status. , 1991, Archives of general psychiatry.

[94]  J. Biederman.  Sudden death in children treated with a tricyclic antidepressant. , 1991, The Medical letter on drugs and therapeutics.

[95]  Judith M. Rumsey,et al.  Cerebral glucose metabolism in adults with hyperactivity of childhood onset. , 1990 .

[96]  L. Sroufe,et al.  Treatment of attentional and hyperactivity problems in children with sympathomimetic drugs: a comprehensive review. , 1990, Journal of the American Academy of Child and Adolescent Psychiatry.

[97]  L. Ewing,et al.  Follow-up of hard-to-manage preschoolers: adjustment at age 9 and predictors of continuing symptoms. , 1990, Journal of child psychology and psychiatry, and allied disciplines.

[98]  R. Barkley,et al.  Side effects of methylphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo-controlled evaluation. , 1990, Pediatrics.

[99]  Mark D. Hoover,et al.  Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline. , 1990, Pediatrics.

[100]  P. Wender,et al.  Bupropion treatment of attention-deficit hyperactivity disorder in adults. , 1990, The American journal of psychiatry.

[101]  D. Sabalesky.  Fluoxetine in adults with residual attention deficit disorder and hypersomnolence. , 1990, The Journal of Neuropsychiatry and Clinical Neurosciences.

[102]  Richard Milich,et al.  Methylphenidate and baseball playing in ADHD children: who's on first? , 1990, Journal of consulting and clinical psychology.

[103]  M. Dulcan.  Using psychostimulants to treat behavioral disorders of children and adolescents. , 1990, Journal of child and adolescent psychopharmacology.

[104]  D. Safer,et al.  Absence of tolerance to the behavioral effects of methylphenidate in hyperactive and inattentive children. , 1989, The Journal of pediatrics.

[105]  S. Hinshaw,et al.  Aggressive, prosocial, and nonsocial behavior in hyperactive boys: dose effects of methylphenidate in naturalistic settings. , 1989, Journal of consulting and clinical psychology.

[106]  B. Birmaher,et al.  Sustained release methylphenidate: pharmacokinetic studies in ADDH males. , 1989, Journal of the American Academy of Child and Adolescent Psychiatry.

[107]  M. Rapport,et al.  Attention deficit hyperactivity disorder and methylphenidate: the relationship between gross body weight and drug response in children. , 1989, Psychopharmacology bulletin.

[108]  D. Klein,et al.  Methylphenidate and growth in hyperactive children. A controlled withdrawal study. , 1988, Archives of general psychiatry.

[109]  R. Barkley.  The effects of methylphenidate on the interactions of preschool ADHD children with their mothers. , 1988, Journal of the American Academy of Child and Adolescent Psychiatry.

[110]  R. Barkley.  Child behavior rating scales and checklists. , 1988 .

[111]  W. Pelham,et al.  Sustained release and standard methylphenidate effects on cognitive and social behavior in children with attention deficit disorder. , 1987, Pediatrics.

[112]  E. D. De Souza,et al.  3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. , 1987, The Journal of pharmacology and experimental therapeutics.

[113]  J. Rapoport,et al.  Neurobiology of attention deficit disorder with hyperactivity: where have we come in 50 years? , 1987, Journal of the American Academy of Child and Adolescent Psychiatry.

[114]  T. Robinson,et al.  Long-lasting effects of escalating doses of d-amphetamine on brain monoamines, amphetamine-induced stereotyped behavior and spontaneous nocturnal locomotion , 1987, Pharmacology Biochemistry and Behavior.

[115]  S. Kutcher.  Assessing and Treating Attention Deficit Disorder in Adolescents , 1986, British Journal of Psychiatry.

[116]  M. Sebrechts,et al.  Components of attention, methylphenidate dosage, and blood levels in children with attention deficit disorder. , 1986, Pediatrics.

[117]  H. Abikoff,et al.  Hyperactive children treated with stimulants. Is cognitive training a useful adjunct? , 1985, Archives of general psychiatry.

[118]  F. Sallee,et al.  Oral pemoline kinetics in hyperactive children , 1985, Clinical pharmacology and therapeutics.

[119]  P. Wender,et al.  A controlled study of Methylphenidate in the treatment of Attention Deficit Disorder, Residual Type, in Adults , 1985, The American journal of psychiatry.

[120]  L. Boswell,et al.  Methylphenidate effects on symptoms of attention deficit disorder in adults. , 1984, Archives of general psychiatry.

[121]  R. Barkley,et al.  Effects of age and Ritalin dosage on the mother-child interactions of hyperactive children. , 1984, Journal of consulting and clinical psychology.

[122]  R. Perry,et al.  Behavioral efficacy of haloperidol and lithium carbonate. A comparison in hospitalized aggressive children with conduct disorder. , 1984, Archives of general psychiatry.

[123]  H. Abikoff,et al.  Does behavior therapy normalize the classroom behavior of hyperactive children? , 1984, Archives of general psychiatry.

[124]  M. Solanto,et al.  The effect of stimulant medication on academic performance, in the context of multimodal treatment, in attention deficit disorders with hyperactivity: two case reports. , 1984, Journal of Clinical Psychopharmacology.

[125]  P. Wender,et al.  An open trial of pargyline in the treatment of attention deficit disorder, residual type , 1983, Psychiatry Research.

[126]  J. Thiessen,et al.  Methylphenidate hydrochloride given with or before breakfast: II. Effects on plasma concentration of methylphenidate and ritalinic acid. , 1983, Pediatrics.

[127]  S Thurber,et al.  Medication and hyperactivity: a meta-analysis. , 1983, The Journal of general psychology.

[128]  R. Milich,et al.  Hyperactivity, inattention, and aggression in clinical practice , 1982 .

[129]  G. Breese,et al.  Clinical studies of methylphenidate serum levels in children and adults. , 1982, Journal of the American Academy of Child Psychiatry.

[130]  S. Schroeder,et al.  Growth hormone and prolactin secretion in adults and hyperactive children: Relation to methylphenidate serum levels , 1981, Psychoneuroendocrinology.

[131]  R. Barkley.  Hyperactive Children: A Handbook for Diagnosis and Treatment , 1981 .

[132]  P. Wender,et al.  Attention deficit disorder ('minimal brain dysfunction') in adults. A replication study of diagnosis and drug treatment. , 1981, Archives of general psychiatry.

[133]  K. Minde,et al.  Evaluation of the relative effectiveness of methylphenidate and cognitive behavior modification in the treatment of kindergarten-aged hyperactive children , 1981, Journal of abnormal child psychology.

[134]  M S Buchsbaum,et al.  Dextroamphetamine. Its cognitive and behavioral effects in normal and hyperactive boys and normal men. , 1980, Archives of general psychiatry.

[135]  D. Cantwell,et al.  Multimodality treatment. A one-year follow-up of 84 hyperactive boys. , 1979, Archives of General Psychiatry.

[136]  L. Arnold,et al.  Methylphenidate vs dextroamphetamine vs caffeine in minimal brain dysfunction: controlled comparison by placebo washout design with Bayes' analysis. , 1978, Archives of general psychiatry.

[137]  J. Swanson,et al.  Time-response analysis of the effect of stimulant medication on the learning ability of children referred for hyperactivity. , 1978, Pediatrics.

[138]  R. Sprague,et al.  Methylphenidate in hyperkinetic children: differences in dose effects on learning and social behavior. , 1977, Science.

[139]  R. Barkley.  A review of stimulant drug research with hyperactive children. , 1977, Journal of child psychology and psychiatry, and allied disciplines.

[140]  C. Conners.  Controlled Trial of Methylphenidate in Preschool Children with Minimal Brain Dysfunction , 1975 .

[141]  G. Weiss,et al.  Hyperactivity in preschoolers and the effect of methylphenidate. , 1975, The American journal of orthopsychiatry.

[142]  C. Conners,et al.  Effect of dextroamphetamine on children. Studies on subjects with learning disabilities and school behavior problems. , 1967, Archives of general psychiatry.

[143]  R. Lachman,et al.  A PSYCHOPHARMACOLOGIC EXPERIMENT IN A TRAINING SCHOOL FOR DELINQUENT BOYS , 1963 .

[144]  G. Solomons,et al.  Hyperkinetic impulse disorder in children's behavior problems. , 1957, Psychosomatic medicine.

[145]  C. Bradley,et al.  AMPHETAMINE (BENZEDRINE) THERAPY OF CHILDREN'S BEHAVIOR DISORDERS* , 1941 .

[146]  C. Bradley.  THE BEHAVIOR OF CHILDREN RECEIVING BENZEDRINE , 1937 .